Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Oct 5, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2021-10-04$2.01/sh−62$125→ 15,198 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021.